Liabilities / Assets
34th percentile
Higher debt load relative to assets than 34% of similar nonprofits.
EIN 31-1611837 • 501(c)3 • Woodbury, NY
Profile
To advance the scientific and medical research related to the diagnosis, treatment, cure and prevention of pancreatic cancer by: increasing funding and support of research into the biological mechanisms and clinical strategies related to the prevention, diagnosis, and treatment of pancreatic cancer; facilitating and enhancing the dialogue among members of the medical and scientific communities about basic and clinical research efforts that relate to pancreatic cancer; heightening public awareness of pancreatic cancer diagnosis, treatment, and prevention and providing informational support for pancreatic cancer patients, their families, and friends.
Refreshing map…
Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.
Liabilities / Assets
34th percentile
Higher debt load relative to assets than 34% of similar nonprofits.
Liabilities / Revenue
44th percentile
Higher debt load relative to revenue than 44% of similar nonprofits.
Net Margin
81st percentile
Higher net margin than 81% of similar nonprofits.
Top Officer Pay
55th percentile
Higher top officer pay than 55% of similar nonprofits.
Top officer pay equals 1.4% of source-year revenue.
Asset Growth
87th percentile
Faster asset growth than 87% of similar nonprofits.
Revenue Growth
90th percentile
Faster revenue growth than 90% of similar nonprofits.
Assets
Down$78,505,397
Down $18,056,235 (-19%) from 2021
Liabilities
Up$8,473,764
Up $4,859,289 (+134%) from 2021
Net Assets
Down$70,031,633
Down $22,915,524 (-25%) from 2021
Revenue
Up$30,446,505
Up $5,978,672 (+24%) from 2021
Expenses
Up$33,834,657
Up $12,108,628 (+56%) from 2021
Net Income
Down-$3,388,152
Down $6,129,956 (-224%) from 2021
Most recent year
2022 • Form 990XML pending. An XML filing is linked for this year, but detailed extraction is still pending.